Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms

J Pediatr. 1984 Aug;105(2):206-11. doi: 10.1016/s0022-3476(84)80114-6.

Abstract

Prospective evaluation of platelet activation and hypercoagulability was performed in 31 patients with Kawasaki syndrome. Most patients had elevated acute-phase reactants when studied during the first 3 weeks of their illness; 17 of 25 (68%) patients had factor VIII activity greater than 150%, 18 of 24 (75%) had fibrinogen greater than 400 mg/dl, and 17 of 31 (55%) had a platelet count greater than 450,000/mm3. Antithrombin III was depressed initially in 17 of 25 (68%) patients. Depleted fibrinolytic activity, as measured by a euglobulin lysis time greater than 300 minutes, was documented in nine of 20 (45%) patients. Plasma beta-thromboglobulin (BTG) measured at 0 to 3 weeks was elevated (greater than 43 ng/ml) in seven of 24 (29%) patients. All patients with coronary artery aneurysms had elevated BTG values. The mean BTG in the group with aneurysms was 72.3 ng/ml when measured during the first 3 weeks after onset of fever, and 87.7 ng/ml at 4 to 7 weeks. The group without aneurysms had mean BTG values of 29.4 and 28.3 ng/ml at 0 to 3 and 4 to 7 weeks, respectively. The difference between the two groups was significant (P less than 0.002) for both the initial and later values. An elevated BTG during the first 3 weeks after onset of fever was highly associated with aneurysm formation in our patients (P less than 0.007). No aneurysms occurred in patients with a normal BTG value.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aneurysm / diagnosis*
  • Aneurysm / etiology
  • Antithrombin III / analysis
  • Blood Platelet Disorders / blood*
  • Blood Platelet Disorders / etiology
  • Blood Platelets / analysis
  • Child, Preschool
  • Coronary Disease / diagnosis*
  • Coronary Disease / etiology
  • Disseminated Intravascular Coagulation / blood*
  • Disseminated Intravascular Coagulation / etiology
  • Fibrinogen / analysis
  • Humans
  • Infant
  • Mucocutaneous Lymph Node Syndrome / blood*
  • Mucocutaneous Lymph Node Syndrome / complications
  • Risk
  • beta-Thromboglobulin / analysis

Substances

  • beta-Thromboglobulin
  • Antithrombin III
  • Fibrinogen